Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
Open Access
- 7 December 2023
- journal article
- review article
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 44 (1) , 29-33
Abstract
Attention‐deficit hyperactivity disorder (ADHD) is characterized by persistent symptoms of inattention, hyperactivity, and impulsivity. Both, stimulant and nonstimulant medications have been approved for the treatment of this disorder. Several Western guidelines recommend the use of prescribed Food and Drug Administration (FDA)‐approved medications for ADHD along with parental training in behavior management and behavioral classroom intervention. In 2022, new Japanese guidelines for ADHD were issued, which recommended school environment management and psychosocial treatment as the first‐line treatment, with pharmacological treatment added as the second‐line treatment. Although Japanese guidelines, including pharmacological treatments, have been established, the guidelines and utilization of ADHD medications across Asian regions are unclear. Therefore, to appropriately evaluate the strategy of pharmacological treatments for ADHD, we investigated Asian regional guidelines for ADHD medication in children. We also reviewed the guidelines in Malaysia, Singapore, India, and the Republic of Korea and found that these guidelines differ from Western guidelines.Keywords
This publication has 22 references indexed in Scilit:
- Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsPediatrics, 2019
- Clinical practice guidelines for the assessment and management of attention-deficit/hyperactivity disorderIndian Journal of Psychiatry, 2019
- Child and adolescent psychiatry in the Far East: A 5‐year follow up on the Consortium on Academic Child and Adolescent Psychiatry in the Far East (CACAP‐FE) studyPsychiatry and Clinical Neurosciences, 2018
- Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databasesThe Lancet Psychiatry, 2018
- Prevalence, incidence and persistence of ADHD drug use in JapanEpidemiology and Psychiatric Sciences, 2018
- ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?Cleveland Clinic Journal of Medicine, 2017
- The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research CenterJournal of the Korean Academy of Child and Adolescent Psychiatry, 2016
- Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011Epidemiology and Health, 2016
- Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in TaiwanPLOS ONE, 2016
- A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)Annals of Pharmacotherapy, 2013